Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
BMC Infectious Diseases
|
June 26, 2024
Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation
Hyung Park, Chang Yu, Liise-Anne Pirofski, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 3, 2025
Experience With Antibody-Based Therapies for COVID-19 for Immunocompromised Patients
Margaret McCort, Helen Tsai, Grace Minamoto, et al.
Medical Mycology
|
September 29, 2023
Shared and unique antibody and B cell profiles in HIV-positive and HIV-negative individuals with cryptococcal meningoencephalitis
Hyunah Yoon, Antonio S Nakouzi, Van Anh Duong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 2, 2022
Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease
Hyunah Yoon, Rachel M Wake, Antonio S Nakouzi, et al.
Nature Communications
|
November 26, 2021
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
Jonathan D Herman, Chuangqi Wang, Carolin Loos, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 24, 2021
Functional Antibodies in COVID-19 Convalescent Plasma
Jonathan D Herman, Chuangqi Wang, Carolin Loos, et al.
Open Forum Infectious Diseases
|
January 25, 2024
COVID-19 Convalescent Plasma Therapy: Long-term Implications
Hyunah Yoon, Yi Li, Keith S Goldfeld, et al.
The Journal of Infectious Diseases
|
July 8, 2025
Comparative analysis of glucuronoxylomannogalactan (GXMGal) and glucuronoxylomannan (GXM) antibody responses and their associations with cryptococcal disease status in people living with HIV
Hyunah Yoon, Antonio S Nakouzi, Rachel M Wake, et al.
Cell Reports. Medicine
|
November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
Jonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
JAMA Internal Medicine
|
December 13, 2021
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial
Mila B Ortigoza, Hyunah Yoon, Keith S Goldfeld, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
BMC Infectious Diseases
|
June 26, 2024
Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation
Hyung Park, Chang Yu, Liise-Anne Pirofski, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 3, 2025
Experience With Antibody-Based Therapies for COVID-19 for Immunocompromised Patients
Margaret McCort, Helen Tsai, Grace Minamoto, et al.
Medical Mycology
|
September 29, 2023
Shared and unique antibody and B cell profiles in HIV-positive and HIV-negative individuals with cryptococcal meningoencephalitis
Hyunah Yoon, Antonio S Nakouzi, Van Anh Duong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 2, 2022
Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease
Hyunah Yoon, Rachel M Wake, Antonio S Nakouzi, et al.
Nature Communications
|
November 26, 2021
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
Jonathan D Herman, Chuangqi Wang, Carolin Loos, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 24, 2021
Functional Antibodies in COVID-19 Convalescent Plasma
Jonathan D Herman, Chuangqi Wang, Carolin Loos, et al.
Open Forum Infectious Diseases
|
January 25, 2024
COVID-19 Convalescent Plasma Therapy: Long-term Implications
Hyunah Yoon, Yi Li, Keith S Goldfeld, et al.
The Journal of Infectious Diseases
|
July 8, 2025
Comparative analysis of glucuronoxylomannogalactan (GXMGal) and glucuronoxylomannan (GXM) antibody responses and their associations with cryptococcal disease status in people living with HIV
Hyunah Yoon, Antonio S Nakouzi, Rachel M Wake, et al.
Cell Reports. Medicine
|
November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
Jonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
JAMA Internal Medicine
|
December 13, 2021
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial
Mila B Ortigoza, Hyunah Yoon, Keith S Goldfeld, et al.
Page
of 2